Comparison of Microplegia Solution and Del Nido Cardioplegia Solution in Coronary Artery Bypass Grafting Surgery: Which One is More Effective?
DOI:
https://doi.org/10.1532/hsf.3955Keywords:
Coronary artery bypass graft, Myocardial protection, Del Nido solution, Cardioplegia, MicroplegiaAbstract
Background: The aim of this study is to compare the efficacy of the microplegia solution and Del Nido cardioplegia solution in coronary artery bypass surgery with clinical, biochemical, and echocardiographic data.
Methods: Three hundred patients, who underwent coronary artery bypass surgery between January 2017 and January 2020, by the same surgical team were included in the study. Preoperative, operative and postoperative data (cardiac biomarker levels, cross-clamp and CPB times, echocardiographic measurements, etc.) of the patients were compared.
Results: In the study, cross-clamp time was significantly shorter in the DN cardioplegia group (55.60 ± 13.49 min/75.58 ± 12.43 min, P = 0.024). No significant difference was observed between the two groups in terms of intensive care stay, extubation time, hospital stay, and cardiopulmonary bypass time. In our study, it was shown that both the left and right ventricular ejection fraction was better protected in the Del Nido cardioplegia group (5.34±3.03 vs. 3.40±2.84, P = 0.017 and 3.82±1.19 vs. 2.28±1.87, P = 0.047, respectively), and the need for inotrope support was lower in this group (28% vs. 44%, P < 0.021). There was no significant difference between the groups, in terms of blood transfusion rates, IABP requirement.
Conclusion: In light of short-term results, we can say that Del Nido cardioplegia provides better myocardial protection than microplegia. In addition, Del Nido cardioplegia can be given as a single dose for 90 minutes of cross-clamp time and therefore can be preferred to increase surgical comfort and reduce cross-clamp times.
References
Albacker TB, Chaturvedi R, Al Kindi AH, et al. 2009. The effect of using microplegia on perioperative morbidity and mortality in elderly patients undergoing cardiac surgery. Interact Cardiovasc Thorac Surg. 9(1):56-60.
Algarni KD, Weisel RD, Caldarone CA, Maganti M, Tsang K, Yau TM. 2013. Microplegia during coronary artery bypass grafting was associated with less low cardiac output syndrome: a propensity-matched comparison. Ann Thorac Surg. 95(5):1532-1538.
Ali JM, Miles LF, Abu-Omar Y, Galhardo C, Falter F. 2018. Global Cardioplegia Practices: Results from the Global Cardiopulmonary Bypass Survey. J Extra Corpor Technol. 50(2):83-93.
Beller JP, Hawkins RB, Mehaffey JH, et al. 2018. Does Preoperative Troponin Level Impact Outcomes After Coronary Artery Bypass Grafting?. Ann Thorac Surg. 106(1):46-51.
Beyersdorf F. 2001. Ischemia-Reperfusion Injury in Cardiac Surgery, Eurekah.com/Landes Bioscience, Austin, Texas, USA.
Buckberg GD, Dyson CW, Emerson RC. 1982. Techniques for administering blood cardioplegia: blood cardioplegia. In: Engelman RM, Levitsky S, eds. Textbook of clinical cardioplegia. Mt. Kisko: Futura. 305-16.
Cayir MC, Yuksel A. 2020. The Use of del Nido Cardioplegia for Myocardial Protection in Isolated Coronary Artery Bypass Surgery. Heart Lung Circ. 29(2):301-307.
Domanski MJ, Mahaffey K, Hasselblad V, et al. 2011. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA. 305(6):585-591.
Gong B, Ji B, Sun Y, Wang G, Liu J, Zheng Z. 2015. Is microplegia really superior to standard blood cardioplegia? The results from a meta-analysis. Perfusion. 30(5):375-382.
Guajardo Salinas GE, Nutt R, Rodriguez-Araujo G. 2017. Del Nido cardioplegia in low risk adults undergoing first time coronary artery bypass surgery. Perfusion. 32(1):68-73.
Hayashida N, Isomura T, Sato T, et al. 1998. Minimally diluted tepid blood cardioplegia. Ann Thorac Surg. 65(3):615-621.
Li Y, Lin H, Zhao Y, et al. 2018. Del Nido Cardioplegia for Myocardial Protection in Adult Cardiac Surgery: A Systematic Review and Meta-Analysis. ASAIO J. 64(3):360-367.
Loberman D, Neely RC, Fitzgerald D. 2014. Modified del Nido cardioplegia in adult cardiac surgery: safety and efficacy. J Cardiol Curr Res. 1: 00042.
Masuda M. 2015. Does cardioplegia during cardiac surgery protect the heart at any time? Eur J Cardiothorac Surg. 48(2):243-244.
Menasché P. 1996. Blood cardioplegia: do we still need to dilute? Ann Thorac Surg. 62(4):957-960.
Menasché P, Touchot B, Pradier F, Bloch G, Piwnica A. 1993. Simplified method for delivering normothermic blood cardioplegia. Ann Thorac Surg. 55(1):177-178.
Mishra P, Jadhav RB, Mohapatra CK, et al. 2016. Comparison of del Nido cardioplegia and St. Thomas Hospital solution - two types of cardioplegia in adult cardiac surgery. Kardiochir Torakochirurgia Pol. 13(4):295-299.
Nissinen J, Biancari F, Wistbacka JO, et al. 2009. Safe time limits of aortic cross-clamping and cardiopulmonary bypass in adult cardiac surgery. Perfusion. 24(5):297-305.
O'Blenes SB, Friesen CH, Ali A, Howlett S. 2011. Protecting the aged heart during cardiac surgery: the potential benefits of del Nido cardioplegia. J Thorac Cardiovasc Surg. 141(3):762-770.
Sanrı US, Ozsin KK, Toktas F, Yavuz S. 2020. Comparison of Del Nido Cardioplegia and Blood Cardioplegia in Terms of Development of Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Grafting. Braz J Cardiovasc Surg. 36(2):158-164.
Thygesen K, Alpert JS, Jaffe AS, et al. 2012. Third universal definition of myocardial infarction. J Am Coll Cardiol. 60(16):1581-1598.
Trescher K, Gleiss A, Boxleitner M, et al. 2017. Short-term clinical outcomes for intermittent cold versus intermittent warm blood cardioplegia in 2200 adult cardiac surgery patients. J Cardiovasc Surg (Torino). 58(1):105-112.
Wang TK, Stewart RA, Ramanathan T, Kang N, Gamble G, White HD. 2013. Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI. Eur Heart J Acute Cardiovasc Care. 2(4):323-333.
Yerebakan H, Sorabella RA, Najjar M, et al. 2014. Del Nido Cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: a propensity matched comparison. J Cardiothorac Surg. 9:141.
